KIR2DL1 and neoplasm: In tumor tissue, NKG2A and KIRs, including KIR2DL1, were predominantly expressed on NK cells (Fig. 4 and Extended Data Fig. 8); these receptors were more highly expressed on a greater percentage of NK cells in patients with lesser pathological regression (Fig. 4).